---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-25-000095"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2025-05-07T23:59:59+00:00"
generated_at: "2026-05-22T08:32:06.558759+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Viemed reports Q1 2025 revenue of $59.1M, up 17% YoY; net income rises 64%

## Summary
- Q1 net revenues $59.1M, 17% increase from $50.6M in Q1 2024.
- Net income $2.6M ($0.06 diluted EPS) vs $1.6M ($0.04) prior year, up 64%.
- Adjusted EBITDA $12.8M, 26% higher than $10.2M in Q1 2024.
- Company provided updated full-year 2025 guidance alongside Q1 results.

## SEC filing metadata
- accession: 0001729149-25-000095
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2025-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000095/0001729149-25-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000095/vmd-20250507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-25-000095
- JSON: https://secwatch.observer/filing/0001729149-25-000095.json
- Plain text: https://secwatch.observer/filing/0001729149-25-000095.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.